scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1020304639 |
P356 | DOI | 10.1007/S40620-013-0027-Y |
P698 | PubMed publication ID | 24430761 |
P2093 | author name string | Gerhard Anton Müller | |
Daniel Patschan | |||
Susann Patschan | |||
Elvira Henze | |||
Katrin Schwarze | |||
Roman Scheidemann | |||
P2860 | cites work | Dysfunctional endothelial progenitor cells in chronic kidney disease | Q84068669 |
Effects of fenofibrate, a PPAR-α ligand, on the haemodynamics of glycerol-induced renal failure in rats | Q84717456 | ||
Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent manner | Q86333861 | ||
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer | Q21328702 | ||
Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity | Q27013011 | ||
The mechanisms of action of PPARs | Q28216953 | ||
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors | Q28276138 | ||
Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira. | Q33234298 | ||
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney | Q33333234 | ||
Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures | Q33385959 | ||
Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival | Q35074059 | ||
Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension | Q35608633 | ||
PPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5'-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells. | Q35608768 | ||
Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis | Q35651689 | ||
Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice | Q36119361 | ||
Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells | Q36318813 | ||
The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? | Q37374031 | ||
Cord blood-derived early outgrowth endothelial progenitor cells | Q37677859 | ||
Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney? | Q37979621 | ||
PPAR agonists for the treatment of cardiovascular disease in patients with diabetes | Q37996437 | ||
Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury | Q39582724 | ||
Activation of Epac stimulates integrin-dependent homing of progenitor cells | Q40046169 | ||
Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence | Q41916873 | ||
Regulation of cerebrovascular endothelial peroxisome proliferator activator receptor alpha expression and nitric oxide production by clofibrate | Q42473259 | ||
Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury | Q42621335 | ||
Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARα deterioration. | Q42749724 | ||
Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells. | Q42878662 | ||
Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in mice | Q44579820 | ||
Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation | Q44796931 | ||
Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism. | Q46939329 | ||
High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway. | Q53206633 | ||
Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. | Q53561437 | ||
Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors | Q62590334 | ||
Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning | Q82554662 | ||
Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis | Q83306839 | ||
The hormone melatonin stimulates renoprotective effects of "early outgrowth" endothelial progenitor cells in acute ischemic kidney injury | Q83493394 | ||
P433 | issue | 1 | |
P304 | page(s) | 37-44 | |
P577 | publication date | 2014-01-16 | |
P1433 | published in | Journal of Nephrology | Q15765408 |
P1476 | title | Fibrate treatment of eEOCs in murine AKI | |
P478 | volume | 27 |
Q41048729 | Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI. | cites work | P2860 |
Search more.